Improved survival in both histologic types of oesophageal cancer in Sweden.
about
Fully covered removable nitinol self-expandable metal stents (SEMS) in malignant strictures of the esophagus: a multicenter analysis.Diverging trends in recent population-based survival rates in oesophageal and gastric cancer.Barrett's esophagus and cancer risk: how research advances can impact clinical practice.Brain metastases in gastrointestinal cancers: is there a role for surgery?Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): study protocol for a randomized controlled trial.A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia.The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis.Endoscopic palliation of advanced esophageal cancerMultimodality therapy for cancers of the esophagus and gastric cardia.TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohortAdenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?Cost-Effectiveness Analysis on Endoscopic Surveillance Among Western Patients With Barrett's Esophagus for Esophageal Adenocarcinoma Screening.Comparative study of self-expanding metal stent and intraluminal radioactive stent for inoperable esophageal squamous cell carcinoma.A comprehensive review of esophageal stents.Education level and survival after oesophageal cancer surgery: a prospective population-based cohort study.Emerging drugs for esophageal cancer.Role of esophageal stents in benign and malignant diseases.Quality of life after esophagectomy for cancer.Palliative treatment of malignant dysphagia with self-expanding metal stents: a 12-year experience.Incidence of carcinoma of the oesophagus and gastric cardia. Changes over time and geographical differences.Imaging of esophageal stent with convex probe endobronchial ultrasound.Association of MDM2 T309G and p53 Arg72Pro polymorphisms and gastroesophageal reflux disease with survival in esophageal adenocarcinoma.The influence of age, sex, and race on the incidence of esophageal cancer in the United States (1992-2006).Surveillance of Barrett's esophagus and mortality from esophageal adenocarcinoma: a population-based cohort study.The influence of surgical factors on persisting symptoms 3 years after esophageal cancer surgery: a population-based study in Sweden.Randomised comparison of the FerX Ella antireflux stent and the ultraflex stent: proton pump inhibitor combination for prevention of post-stent reflux in patients with esophageal carcinoma involving the esophago-gastric junction.Quality of life of esophagectomized patients: adenocarcinoma versus squamous cell carcinoma.Prior chemoradiotherapy is associated with a higher life-threatening complication rate after palliative insertion of metal stents in patients with oesophageal cancer.Novel stent in the palliation of malignant esophageal strictures: a retrospective study.Utility of dysphagia grade in predicting endoscopic ultrasound T-stage of non-metastatic esophageal cancer.The role of identity in adjustment among survivors of oesophageal cancer.UEG Week 2015 Poster Presentations
P2860
Q30454800-5054C81B-B5F4-4DB0-B45C-62BB60ECB221Q31074884-33981DBB-BC40-450B-BB5D-DF5E7A07F5B1Q33959620-D5446643-DCFA-4D56-A93F-1AA10804F321Q34358783-98462CB1-A1BB-4A07-9571-E16FAA5CF53AQ34469769-1E6DF4BE-FB0C-4854-964B-8E49C0606267Q34718582-227A21B8-5662-4C1E-8F7D-A3BB197891BCQ34786281-2A542A4A-6D57-4932-ABBB-D94F5ECC5AC6Q35600033-7291B4ED-4B44-4AE4-B8B1-C539FDF7E525Q35641236-30A9958A-F8FA-4736-9D64-E353CEEE4F14Q35760858-313C9C1E-E665-4D7C-8E65-5D2CF244335FQ35790574-BF2F979F-A4BD-417B-BBC2-E53449348039Q36195716-158CA5A4-3ED7-44CC-BAD0-F99677EA2F88Q36489928-3F5FA063-BC70-4E90-83C5-51449366B03DQ36496966-EBCFA129-00B5-4D2B-A103-8CA99BEA9C1FQ37374387-00440DC7-BF6D-46B9-A6F9-38298D95CB00Q37488281-721B2F07-F465-4E4D-959D-7F6046440DF2Q37661341-CDB563CB-97AD-464F-9B7F-10FB79B549A7Q37965689-A4585A43-132D-483C-A95F-215F31CCE03CQ39341875-89CB7953-D3AD-4894-8DAD-478CCDACF1C9Q39813002-D0DE5883-4E1D-4BB3-B123-DDC873694B81Q40805229-444C5299-D52E-4A88-BD52-2B57F5BBBC30Q44000617-DF007565-9E0F-4D83-BA58-C918928470DFQ45323293-17B09746-F1EB-4C66-9DBD-788F6374266CQ45740170-1ADABFF6-2396-4CAE-B8B3-F90A6652CDC1Q45909793-490F1F58-B1D2-4FC8-AF7D-5034854F9EC8Q46646034-A0E37E85-4DA4-4F47-AF36-71F945FF9853Q48034452-432FFC1D-0219-4F2D-8953-7BE3E36813B2Q51169133-6CEAA56A-E7FE-4E01-BA54-3DAF0A0B1895Q51577837-4C69B914-BD22-4C3E-B920-FA6FD921AEF2Q52916114-DCC4C27F-2E15-43E8-BA4B-F3F964A9D73DQ53062204-763A4E2C-6EC5-453B-B573-E4109E8A15A7Q56934656-96B38237-7C6D-4831-AC09-74D8107BDAF7
P2860
Improved survival in both histologic types of oesophageal cancer in Sweden.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Improved survival in both histologic types of oesophageal cancer in Sweden.
@en
type
label
Improved survival in both histologic types of oesophageal cancer in Sweden.
@en
prefLabel
Improved survival in both histologic types of oesophageal cancer in Sweden.
@en
P2860
P356
P1476
Improved survival in both histologic types of oesophageal cancer in Sweden.
@en
P2093
Martin Sundelöf
P2860
P304
P356
10.1002/IJC.10420
P577
2002-06-01T00:00:00Z